Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06446037 · ClinicalTrials.gov registry record · Early Phase 1
Assessment of Gesture Accuracy of a Prosthesis Control System
A Early Phase 1 study of Upper Limb Amputation Below Elbow (Injury), sponsored by Phantom Neuro.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06446037: Completed Early Phase 1 study of Upper Limb Amputation Below Elbow (Injury), sponsored by Phantom Neuro.
NCT06446037 is a Early Phase 1 study of Upper Limb Amputation Below Elbow (Injury) that has completed, run by Phantom Neuro. The registered enrollment target is 11 participants, below the 86-participant average among 3 other Upper Limb Amputation Below Elbow (Injury) trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06446037, a Early Phase 1 study of Upper Limb Amputation Below Elbow (Injury), has completed, sponsored by Phantom Neuro.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is evaluating the performance of prosthesis control system, referred to as Phantom X, in able bodied individuals and individuals with upper limb amputation at the forearm level.
Primary Outcome
Percentage of hand gestures accurately decoded by Phantom X algorithm
Conditions Studied
Interventions
- DEVICE Non-invasive EMG band instrumentation
Study Locations (1)
Texas
- Phantom Neuro Inc. Operational Headquarters - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-08-13 |
| Est. Completion | 2025-04-18 |
| Phase | Early Phase 1 |
What the finished NCT06446037 record still lists
NCT06446037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 86-participant average among 3 other Upper Limb Amputation Below Elbow (Injury) trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Upper Limb Amputation Below Elbow (Injury) appearing as the primary indexed condition, and to 1 intervention - of which Non-invasive EMG band instrumentation is the first listed.
NCT06446037 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06446037 about?
NCT06446037 is a clinical study titled "Assessment of Gesture Accuracy of a Prosthesis Control System". The study is evaluating the performance of prosthesis control system, referred to as Phantom X, in able bodied individuals and individuals with upper limb amputation at the forearm level.
What is the current status of trial NCT06446037?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2024-08-13. Estimated completion is 2025-04-18.
What conditions does trial NCT06446037 study?
This clinical trial studies the following conditions: Upper Limb Amputation Below Elbow (Injury).
What interventions are being tested in trial NCT06446037?
The interventions under investigation include: Non-invasive EMG band instrumentation (DEVICE).
Who is sponsoring clinical trial NCT06446037?
This trial is sponsored by Phantom Neuro, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06446037 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Upper Limb Amputation Below Elbow (Injury)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI